Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations

Fig. 1

Mutational Landscapes of African and European Ancestry Breast Cancer Patients (AA and EA, respectively). Oncoplots show the top 15 pathogenic mutations in A all patients (AA n = 621, EA n = 2804), B patients with HR+/HER2- disease (AA n = 220, EA n = 1279), and C patients with triple-negative breast cancer (TNBC) (AA n = 143, EA n = 400)

Back to article page